Atai life sciences reports fourth quarter and full year 2023 financial results and provides corporate and clinical highlights

New york and berlin, march 28, 2024 (globe newswire) -- atai life sciences  (nasdaq: atai) (“atai” or “company”) a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced fourth quarter and full year 2023 financial results and provided corporate and clinical highlights.
ATAI Ratings Summary
ATAI Quant Ranking